Heartbeam, Inc. (BEAT)
Nasdaq: BEAT · Surgical & Medical Instruments & Apparatus · Santa Clara, CA · filing with the SEC since 2019
Who owns Heartbeam, Inc.
As filed with the SECHolders of 5% or more
1
Strome Mark E holds 6.8% of Common Stock, par value $.0001 per share, as its SCHEDULE 13D/A filed Aug 13, 2026 says.
Directors and officers
11
report now, of 14 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Strome Mark E
SCHEDULE 13D/A · filed Aug 13, 2026 · Common Stock, par value $.0001 per share
What BEAT reports owning in othersstakes of 5% or more, and other ties
Heartbeam, Inc. reports no stake in another company in the record.
Insider tradesForm 4
3sales
9purchases
0sales on a scheduled plan
2people selling
$1.1Msold, in dollars
$1.0Mbought, in dollars
Open-market trades on Form 4 from Oct 9, 2025 to Oct 9, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 9, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window9 of 14 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Strome Mark E | director | 1 | $900,000 | 0 | 1 | $600,000 |
| De Urioste George | director | 2 | $200,000 | 0 | 0 | $0 |
| Ferrari Richard M | Exec Chm of the BOD | 0 | $0 | 0 | 2 | $100,000 |
| Vajdic Branislav | President | 0 | $0 | 0 | 1 | $0 |
| Eno Robert Paul | President | 0 | $0 | 0 | 1 | $0 |
| Cruickshank Tim | CFO | 0 | $0 | 0 | 1 | $0 |
| Elfrink Willhem | director | 0 | $0 | 0 | 1 | $200,000 |
| Jaff Michael R | director | 0 | $0 | 0 | 1 | $0 |
| Ortigas-Wedekind Marga | director | 0 | $0 | 0 | 1 | $0 |